Author Correction: Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1

Nat Commun. 2020 Feb 25;11(1):1139. doi: 10.1038/s41467-020-15012-6.

Julia Minderjahn¹, Andreas Schmidt², Andreas Fuchs³, Rudolf Schill⁴, Johanna Raithel¹, Magda Babina⁵, Christian Schmidl⁶, Claudia Gebhard^{1

6}, Sandra Schmidhofer^{1

7}, Karina Mendes¹, Anna Ratermann^{1

8}, Dagmar Glatz^{1

9}, Margit Nützel¹, Matthias Edinger^{1

6}, Petra Hoffmann^{1

6}, Rainer Spang⁴, Gernot Längst³, Axel Imhof², Michael Rehli^{10

11}

¹ Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
² Biomedical Center, Protein Analysis Unit, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Strasse 9, 82152, Planegg-Martinsried, Germany.
³ Biochemistry Centre Regensburg (BCR), University of Regensburg, 93053, Regensburg, Germany.
⁴ Statistical Bioinformatics Department, Institute of Functional Genomics, University of Regensburg, 93053, Regensburg, Germany.
⁵ Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁶ Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Medical Center Regensburg, 93053, Regensburg, Germany.
⁷ AstraZeneca, Tinsdaler Weg 183, 22880, Wedel, Germany.
⁸ Rentschler Biopharma SE, 88471, Laupheim, Germany.
⁹ Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada, H1T 2M4.
¹⁰ Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany. michael.rehli@ukr.de.
¹¹ Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Medical Center Regensburg, 93053, Regensburg, Germany. michael.rehli@ukr.de.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.